Glucocorticoids inhibit stress-induced phosphorylation of CREB in corticotropin-releasing hormone neurons of the hypothalamic paraventricular nucleus

Neuroendocrinology

Volumn 66, Issue 2, 1997, Pages 86-97

  Légrádi, Gábor ^a   Holzer, David ^a   Kapcala, Leonard P ^c   Lechan, Ronald M ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenal steroids; Corticotropin releasing hormone; CREB; Paraventricular nucleus; Phosphorylation; Stress

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEXAMETHASONE; ETHER; GLUCOCORTICOID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; GIANT CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; STRESS; THALAMUS MIDLINE NUCLEUS;

ACTIVATING TRANSCRIPTION FACTOR 2; ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DEXAMETHASONE; GLUCOCORTICOIDS; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PHOSPHORYLATION; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL; TRANSCRIPTION FACTORS;

EID: 1842293297     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000127224     Document Type: Article

References (53)

1. Vale W, Spiess J, Rivier C, Rivier J: Characterization of a 41-rcsidue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 1981:213:1394-1397.
2. Rivier C, Plotskv PM: Mediation by corticotropin releasing factor (CRF) of adenohypophysial hormone secretion. Annu Rev Physiol 1986:48:475-494.
3. Bateman A, Singh A, Krai T, Solomon S: The immune-hypothalamic-pituitarv-adrenal axis. EndocrRev 1989:10:91-112.
4. Sawchenko PE, Imaki T, Potter E, Kovacs K, Imaki J, Vale W: The functional neuroanatomy of corticotropin-releasing factor. Ciba Found Symp 1993:172:5-29.
5. Keller-Wood ME, Dallman MF: Corticosteroid inhibition of ACTH secretion. Endocr Rev 1984;5:1-24.
6. Emanuel RL, Girard DM, Thull DL, Majzoub JA: Second messengers involved in the regulation of corticotropin-releasing hormone mRNA and peptide in cultured rat fetal hypothalamic primary cultures. Endocrinology 1990;126:3016-3021.
7. Seasholtz AF, Thompson RC, Douglas JD: Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene. Mol Endocrinol 1988:2:1311-1319.
8. Adler GK, Smas GM, Fiandaca M, Frim DM, Majzoub JA: Regulated expression of the human corticotropin releasing hormone gene by cyclic AMP. Mol Cell Endocrinol 1990;70: 165-174.
9. Itoi K, Horiba N, Tozawa F, Sakai Y, Sakai K, Abe K, Demura H, Suda T: Major role of 3',5'-cyclic adenosine monophosphate-dependent protein kinase A pathway in corticotropin-releasing factor gene expression in the rat hypothalamus in vivo. Endocrinology 1996:137: 2389-2396.
10. Montminy MR, Bilezikjian LM: Binding of a nuclear protein to the cyclic AMP-responsive element of the somatostatin gene. Nature 1987: 328:175-178.
11. Hagiwara M, Brindle P, Harootunian A, Armstrong R, Rivier J, Vale W, Tsien R, Montminy MR: Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A. Mol Cell Biol 1993; 13:4852-4859.
12. Gonzalez GA, Montminy MR: Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 1989;59:675-680.
13. Spengler D, Rupprecht R, Phivan L, Holsboer F: Identification and characterization of a 3',5'-cyelic-adenosine monophosphate-responsive element in the human corticotropin-rcleasing hormone gene promoter. Mol Endocrinol 1992; 6:1931-1941.
14. Guardiola-Diaz HM, Boswell C, Seasholtz AF: The c.AMP-responsive element in the corticotropin-releasing hormone gene mediates transcriptional regulation by depolarization. J Biol Chem 1994:269:14784-14791.
15. Ginty DD, Komhauser JM, Thompson MA, Bading H, Mayo KE, Takahashi JS, Greenberg ME: Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and a circadian clock. Science 1993:260:238-241.
16. Konradi C, Cole RL, Heckers S, Hyman SE: Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J Ncu-rosci 1994;14:5623-5634.
17. Gu G, Rojo AA, Zee MC, Yu J, Simerly RB: Hormonal regulation of CREB phosphorylation in the anterovcntral periventricular nucleus. J Neurosci 1996;16:3035-3044.
18. Lcgrkti G, Holzer D, Hitz S, Lechan RM: Glucocorticoids inhibit phosphorylation of CREB in hvpophysiotropic CRH neurons. 10th lnt Congr of Endocrinology. San Fransisco, June 1996. Program and Abstracts vol. I. p 123.
19. Hsu SM, Raine L, Fanger H: The use of avidin-biotin-peroxidase complex (ABC) in immuno-pcroxidase techniques: A comparison between ABC and unlabcled antibody (PAP) procedures. J Histochcm Cytochcm 1981:29:577-580.
20. Swanson LW: Brain Maps: Structure of the Rat Brain. Amsterdam. Elsevier. 1992.
21. Sawchenko PE: Effects of catecholamine-depleting medullary knife cuts on corticotropin-releasing factor and vasopressin immunoreac-tivity in the hypothalamus of normal and steroid-manipulated rats. Neurocndocrinology 1988;48:459-470.
22. Carlson DE, De Maria FJ, Campbell RW, Gann DS: Behavioral and hormonal influence on blood volume restitution after hemorrhage in swine. AmJ Physiol 1989;256: R207-R216.
23. Chrousos GP, Gold PW: The concepts of stress and stress system disorders: Overview of physical and behavioral homeostasis. JAMA 1992: 267:1244-1252.
24. Kovacs KJ, Sawchenko PE: Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory' neurons. J Neurosci 1996; 16:262-273.
25. Hokfelt T, Fahrenkrug J, Tatcmoto K, Mutt V, Werner S, Hulling AL, Terenius L, Chang KJ: The PHI (PHI-27)corticotropin-rcleasing factor/enkephalin immunoreactivc hypothalamic neuron: Possible morphological basis for integrated control of prolactin, corticotropin, and growth hormone secretion. Proc Nall Acad Sci USA 1983:80:895-898.
26. Cunningham ET Jr, Sawchenko PE: Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol 1988:274:60-76.
27. Liposits ZS, Phclix C, Pauli WK: Adrenergic innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. Histochemistry 1986:84:201-205.
28. Plotsky PM, Cunningham ET, Widmaier EP: Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr Rev 1989:10:437-458.
29. Iloi K, Suda T, Tozawa F, Dobashi I, Ohmori N, Sakai Y, Abe K, Demura H: Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates corticotropin-releasing factor gene expression in conscious rats. Endocrinology 1994; 135:2177-2182.
30. Darlington DN, Barradough CA, Gann DS: Hypotensive hemorrhage elevates corticotropin-releasing hormone messenger ribonucleic acid (mRNA) but not vasopressin mRNA in rat hypothalamus. Endocrinology 1992:130:1281-1288.
31. Ericsson A, Kovacs KJ, Sawchenko PE: A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 1994;14:897-913.
32. Pacak K, Armando I, Fukuhara K, Kvetansky R, Palkovits M, Kopin IJ, Goldstein DS: Noradrenergic activation in the paraventricular nucleus during acute and chronic immobilization stress in rats: An in vivo microdialysis study. Brain Res 1992:589:91-96.
33. Arimura A: Pituitary adenylate cyclase-activating polypeptide (PACAP): Discovery and current status of research. Regul Pept 1992:37: 287-303.
34. Legradi G, Shioda S, Lechan RM, Arimura A: Immunohistochemical localization of pituitary adenylate cyclase-activating polypeptide (PACAP) in catecholamine neurons of the brainstem (abstract). 2nd Int Symp on VIP. PACAP. and Related Peptides. New Orleans. October 1995.
35. Assenmacher I, Szafarczyk A, Alonso G, Ixart G, Barbanel G: Physiology of neural pathways affecting CRH secretion. Ann NY Acad Sci 1987;512:149-161.
36. Makino S, Gold PW, Schulkin J: Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res 1994:640:105-112.
37. Imaki T, Nahan J-L, Rivier C, Sawchenko PE, Vale W: Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J Neurosci 1991: 11:585-599.
38. Kovacs KJ, Mczey E: Dexamethasone inhibits corticotropin-releasing factor gene expression in the rat paraventricular nucleus. Neuroendo-crinologv 1987;46:365-368.
39. Agnati LF, Fuxe K, Yu Z-Y, Harfstrand A, Okret S, Wikstrom A-C, Goldstein M, Zoli M, Vale W, Gustafsson J-A: Morphometrical analysis of the distribution of corticotrophin releasing factor, glucocorticoid receptor and phenyl-ethanolamine-N-methyl transferase immuno-reactivc structures in the paraventricular hypothalamic nucleus of the rat. Neurosci Lett 1985:54:147-152.
40. Cintra A, Fuxe K, Harfstrand A, Agnati LF, Wikstrom A-C, Okret S, Vale W, Gustafsson J-A: Presence of glucocorticoid receptor immu-noreactive neurons of the rat di- and telencephalon. Neurosci Lett 1987:77:25-30.
41. Truss M, Beato M: Steroid hormone receptors: Interaction with deoxyribonucleic acid and transcription factors: Endoer Rev 1993:14: 459-479.
42. Vamvakopoulos NC, Chrousos GP: Hormonal regulation of human corticotropin-releasing hormone gene expression: Implications for the stress response and immune/inflammatory reaction. Endocr Rev 1994:15:409-420.
43. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR: Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element. Science 1990:249: 1266-1272.
44. Imai E, Miner JN, Mitchell JA, Yamamoto KR, Granner DK: Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpy-ruvate carboxykinase gene to glucocorticoids. J Biol Chem 1993:268:5353-5356.
45. Peters MJ, Adcock IM, Brown CR, Barnes PJ: J-Adrenoceptor agonists interfere with glucocorticoid receptor DNA binding in rat lung. Eur J Pharmacol 1995:289:275-281.
46. Adcock IM, Brown CR, Gelder CM, Shirasaki H, Peters MJ: Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. Am J Physiol 1995;268:C331-C338.
47. Pacak K, Palkovits M, Kvetanskv R, Matem P, Han C, Kopin IJ, Goldstein DS: Catechol-amir.ergic inhibition by hypcrcortisolemia in the paraventricular nucleus of conscious rats. Endocrinology 1995:136:4814-4819.
48. Reul JMHM, de Kloet ER: Two receptor system for corticosterone in rat brain: Microdistribution and differential occupation. Endocrinology 1985:117:2502-2511.
49. Souza RJ, Tannery NH, Lafer EM: In situ hybridization mapping of glucocorticoid receptor messenger ribonucleic acid in rat brain. Mol Endocrinol 1989:3:481-494.
50. Herman JP, Schafer MKH, Young EA, Thompson R, Douglass J, Akil H, Watson SJ: Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pitu-itarv-adrenocortical axis. J Neurosci 1989:9: 3072-3082.
51. Cullinan WE, Herman JP, Watson SJ: Ventral subicular interaction with the hypothalamic paraventricular nucleus: Evidence for a relay in the bed nucleus of the stria terminalis. J Comp Neurol 1993:332:1-20.
52. Kovacs K, Kiss JZ, Makara GB: Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy. Neuroendocrinology 1986:44:229-234.
53. Slusher MA: Effects of cortisol implants in the brainstem and ventral hippocampus on diurnal corticosteroid levels. Exp Brain Res 1966:1: 184-194.